Here in EBV-positive B-lymphoma cells, circEAF2 specifically targeted miR-BART19-3p, upregulated APC, and suppressed downstream β-catenin, indicative a viral miRNA-mediated mechanism underlying EBV + DLBCL progression. The gene discussed is APC; the disease is diffuse large B-cell lymphoma.